Mather Group
RVMD icon

Mather Group’s Revolution Medicines RVMD Stock Holding History

Mather Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.5K Buy
+202
New +$40K ﹤0.01% 1218

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak Pty Ltd
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Wedmont Private Capital
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Mather Group's RVMD Position: Q3 2026 in Review

Mather Group opened a new position in Revolution Medicines (RVMD) in Q3 2026: 202 shares worth $41.5K. The stake represents ﹤0.01% of the portfolio and ranks #1218 among its holdings.

136 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Mather Group held 202 shares of Revolution Medicines worth $41.5K as of Q3 2026.
  • Revolution Medicines was a new Mather Group position in Q3 2026.
  • Revolution Medicines made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1218 holding.
  • 136 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.